Skip to main content

Advertisement

Log in

Reversible large-scale network disruption correlates with neurocognitive improvement in HIV-associated minor neurocognitive disorder with combined anti-retroviral therapy intensification: a prospective longitudinal resting-state functional magnetic resonance imaging study

  • Original Article
  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract

Objective

HIV-associated neurocognitive disorder (HAND) affects multiple cognitive domains and currently, the neuropsychological testing is the gold standard to identify these deficits. The aim of this longitudinal 12-month pilot study is to determine the effect of intensified combination antiretroviral therapy (cART) on rs-fMRI in virally suppressed (both in CSF and blood) patients with active HAND (those who have progressive neurocognitive impairment) and correlated with neurocognitive function tests.

Methods

In this pilot study, we have evaluated sixteen patients with active HAND with viral suppression in both blood and CSF to study the effect of cART on functional connectivity. Participants underwent rs-fMRI at the baseline (time point-1 (TP-1) and 12-month visits (time point-2 (TP-2)). Connectivity in the five major networks was measured at TP-1 and TP-2 using the seed-based approach. All the participants underwent a five-domain neuropsychological battery at TP-1 and TP-2. Neurocognitive scores (NC) as well as blood and CSF markers were correlated with functional connectivity (FC).

Results

There was a significant increase in the FC between the two time points within the executive, salience, default mode, dorsal attention, and visual networks at voxel level threshold of p < 0.001 and cluster level threshold of p < 0.05 and corrected for false detection rate (FDR). The neurocognitive scores were positively correlated with all the networks at similar cluster and voxel level thresholds.

Conclusions

These results indicate that rs-fMRI can be potentially used as one of the biomarkers for treatment efficacy in HAND.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Data Availability

Data is available and some data can be shared upon request.

References 

  1. Heaton R, Clifford D, Franklin D et al (2010) HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy CHARTER Study. Neurology 75(23):2087–2096

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Cysique LA, Brew BJ (2011) Prevalence of non-confounded HIV-associated neurocognitive impairment in the context of plasma HIV RNA suppression. J Neurovirol 17(2):176–183

    Article  PubMed  Google Scholar 

  3. Tozzi V, Balestra P, Bellagamba R et al (2007) Persistence of neuropsychologic deficits despite long-term highly active antiretroviral therapy in patients with HIV-related neurocognitive impairment: prevalence and risk factors. JAIDS J Acquir Immune Defici Syndr 45(2):174–182

    Article  Google Scholar 

  4. Chang L, Speck O, Miller EN et al (2001) Neural correlates of attention and working memory deficits in HIV patients. Neurology 57:1001–1007

    Article  CAS  PubMed  Google Scholar 

  5. Chang L, Yakupov R, Nakama H, Stokes B, Ernst T (2008) Antiretroviral treatment is associated with increased attentional load-dependent brain activation in HIV patients. J NeuroImmune Pharmacol 3:95–104

    Article  CAS  PubMed  Google Scholar 

  6. Ernst T, Chang L, Jovicich J, Ames N, Arnold S (2002) Abnormal brain activation on functional MRI in cognitively asymptomatic HIV patients. Neurology 59(9):1343–1349

    Article  CAS  PubMed  Google Scholar 

  7. Caldwell JZK, Gongvatana A, Navia BA et al (2014) Neural dysregulation during a working memory task in human immunodeficiency virus-seropositive and hepatitis C coinfected individuals. J Neurovirol 20:398–411

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Plessis SD, Vink M, Joska JA, Koutsilieri E, Stein DJ, Emsley R (2014) HIV infection and the fronto-striatal system: a systematic review and meta-analysis of fMRI studies. AIDS 28:803–811

    Article  PubMed  Google Scholar 

  9. Thames AD, Sayegh P, Terashima K et al (2016) Increased subcortical neural activity among HIV+ individuals during a lexical retrieval task. Neurobiology of disease 92:175–182

    Article  PubMed  Google Scholar 

  10. Thomas JB, Brier MR, Snyder AZ, Vaida FF, Ances BM (2013) Pathways to neurodegeneration: effects of HIV and aging on resting-state functional connectivity. Neurology 80(13):1186–1193

    Article  PubMed  PubMed Central  Google Scholar 

  11. Guha A, Wang L, Tanenbaum A et al (2016) Intrinsic network connectivity abnormalities in HIV-infected individuals over age 60. J Neurovirol 22(1):80–87

    Article  CAS  PubMed  Google Scholar 

  12. Wang X, Foryt P, Ochs R et al (2011) Abnormalities in resting-state functional connectivity in early human immunodeficiency virus infection. Brain connectivity 1(3):207–217

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Ipser JC, Brown GG, Bischoff-Grethe A et al (2015) HIV infection is associated with attenuated frontostriatal intrinsic connectivity: a preliminary study. J Int Neuropsychol Soc 21(3):203–213

    Article  PubMed  PubMed Central  Google Scholar 

  14. Ortega M, Brier MR, Ances BM (2015) Effects of HIV and combination antiretroviral therapy (cART) on cortico-striatal functional connectivity. AIDS 29(6):703

    Article  CAS  PubMed  Google Scholar 

  15. du Plessis L, Paul RH, Hoare J et al (2017) Resting-state functional magnetic resonance imaging in clade C HIV: within-group association with neurocognitive function. J Neurovirol 23(6):875–885

    Article  PubMed  PubMed Central  Google Scholar 

  16. Ann HW, Jun S, Shin NY et al (2016) Characteristics of resting-state functional connectivity in HIV-associated neurocognitive disorder. PLoS ONE 11(4):e0153493

    Article  PubMed  PubMed Central  Google Scholar 

  17. Chaganti JR, Heinecke A, Gates TM, Moffat KJ, Brew BJ (2017) Functional connectivity in virally suppressed patients with HIV-associated neurocognitive disorder: a resting-state analysis. AJNR Am J Neuroradiol 38(8):1623–1629

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Zhuang Y, Qiu X, Wang L et al (2017) Combination antiretroviral therapy improves cognitive performance and functional connectivity in treatment-naïve HIV-infected individuals. J Neurovirol 23(5):704–712

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Corrêa DG, Zimmermann N, Ventura N et al (2017) Longitudinal evaluation of resting-state connectivity, white matter integrity and cortical thickness in stable HIV infection: Preliminary results. Neuroradiol J 30(6):535–545

    Article  PubMed  PubMed Central  Google Scholar 

  20. Gates TM, Cysique LA, Siefried KJ, Chaganti J, Moffat KJ, Brew BJ (2016) Maraviroc-intensified combined antiretroviral therapy improves cognition in virally suppressed HIV-associated neurocognitive disorder. AIDS 30(4):591–600

    Article  CAS  PubMed  Google Scholar 

  21. Whitfield-Gabrieli S, Nieto-Castanon A (2012) Conn: a functional connectivity toolbox for correlated and anticorrelated brain networks. Brain Connect 2(3):125–41

    Article  Google Scholar 

  22. Behzadi Y, Restom K, Liau J, Liu TT (2007) A component based noise correction method (CompCor) for BOLD and perfusion based fMRI. Neuroimage 37(1):90–101

    Article  PubMed  Google Scholar 

  23. Cole JH, Caan MWA, Underwood J, De Francesco D, van Zoest RA, Wit FWNM, Mutsaerts HJMM, Leech R, Geurtsen GJ, Portegies P, Majoie CBLM, Schim van der Loeff MF, Sabin CA, Reiss P, Winston A, Sharp DJ, Comorbidity in Relations to AIDS (COBRA) Collaboration (2018) No evidence for accelerated aging-related brain pathology in treated human immunodeficiency virus: longitudinal neuroimaging results from the comorbidity in relation to AIDS (COBRA) project. Clin Infect Dis. 66(12):1899–1909. https://doi.org/10.1093/cid/cix1124

    Article  PubMed  Google Scholar 

  24. Tanaka S, Manabu Honda M, Sadato N (2005) Modality-specific cognitive function of medial and lateral human Brodmann area 6. J Neurosci 25(2):496–501

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Burgess PW, Wu H-C (2013) Rostral prefrontal cortex (Brodmann area 10): metacognition in the brain. In: Stuss DT, Knight RT (eds) Chapter 31: Principles of frontal lobe function. Oxford University Press, New York

  26. Li R, Wang W, Wang Y, Peters S, Zhang X, Li H (2019) Effects of early HIV infection and combination antiretroviral therapy on intrinsic brain activity: a cross-sectional resting-state fMRI study. Neuropsychiatr Dis Treat 15:883–894

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Ramirez-Mahaluf JP, Perramon J, Otal B et al (2018) Subgenual anterior cingulate cortex controls sadness-induced modulations of cognitive and emotional network hubs. Sci Rep 8:8566. https://doi.org/10.1038/s41598-018-26317-4

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Menon V (2015) Salience network. In: Toga AW (ed) Brain mapping: an encyclopedic reference, vol 2. Elsevier Inc., London, UK, pp 597–611

  29. Steven FL, Hurley RA, Hurley RA, Hayman AL, Taber KH (2011) Anterior cingulate cortex: unique role in cognition and emotion. J Neuropsychiatry Clin Neurosci 23(2):121–125

    Article  Google Scholar 

  30. Janssen MAM, Hinne M, Janssen RJ et al (2017) Resting-state subcortical functional connectivity in HIV-infected patients on long-term cART. Brain Imaging Behav 11(5):1555–1560. https://doi.org/10.1007/s11682-016-9632-4

    Article  PubMed  Google Scholar 

  31. Sakurai Y (2017) Brodmann areas 39 and 40: human parietal association area and higher cortical function. Brain and nerve 69:461–469. https://doi.org/10.11477/mf.1416200765

    Article  PubMed  Google Scholar 

  32. Wright PW, Heaps JM, Shimony JS, Thomas JB, Ances BM (2012) The effects of HIV and combination antiretroviral therapy on white matter integrity. AIDS 26(12):1501–1508

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Joga Chaganti.

Ethics declarations

Ethics approval and informed consent

This is a prospective longitudinal design (“The patient group was chosen from the study which was previously published in AIDS (2016, 30:591–600)”, at St Vincent’s Hospital (SVH), Sydney, Australia (ClinicalTrials.gov Identifier: NCT01449006).

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chaganti, J., Gates, T.M. & Brew, B.J. Reversible large-scale network disruption correlates with neurocognitive improvement in HIV-associated minor neurocognitive disorder with combined anti-retroviral therapy intensification: a prospective longitudinal resting-state functional magnetic resonance imaging study. Neurol Sci 44, 3261–3269 (2023). https://doi.org/10.1007/s10072-023-06783-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-023-06783-z

Keywords

Navigation